For in vitro diagnostic use. Others D-DI2 cobas t IVD D-DI2 CPS_000555 Tina-quant D-Dimer Gen.2 07429410190 D-Dimer Gen.2 cobas t 100T D-DI2 07613336119525 Reagents, kits 100 tests cobas t 511/711 true 06589367190 D-Dimer Gen. 2 cobas t411 D-DI2 04015630932351 Reagents, kits 5 × 40 tests cobas t 411 true 09311106190 D-Dimer Gen.2 cobas t 100T D-DI2 07613336191262 Reagents, kits 100 tests cobas t 511/711 true ms_07429410190 D-DI2 Tina-quant D-Dimer Gen.2 en 4 FF000000058E490E FF00000001E1140E 07429410190 7479 cobas t 511 7480 cobas t 711 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro assay for the quantitative immunological determination of fibrin degradation products (D‑dimer and X‑oligomers) in human citrated plasma on the indicated cobas t analyzers.In conjunction with a non‑high clinical probability assessment, a normal D‑dimer result (< 0.5 μg FEU/mL) is intended as an aid in the exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE). en ms_09311106190 D-DI2 Tina-quant D-Dimer Gen.2 en 4 FF000000058E480E FF0000000463810E 09311106190 7479 cobas t 511 7480 cobas t 711 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro assay for the quantitative immunological determination of fibrin degradation products (D‑dimer and X‑oligomers) in human citrated plasma on the indicated cobas t analyzers.In conjunction with a non‑high clinical probability assessment, a normal (FREFFibrinogen Equivalent Unit/mL) result excludes deep vein thrombosis (DVT) and pulmonary embolism (PE) with high sensitivity. en